The journey from a concept to a marketed pharmaceutical drug is long and complex, requiring a robust supply chain of specialized chemicals. Among these, versatile chemical intermediates are indispensable for researchers and manufacturers alike. 4-Amino-2-chloro-6,7-dimethoxyquinazoline, identified by CAS number 23680-84-4, is one such compound, offering significant versatility in pharmaceutical development.

NINGBO INNO PHARMCHEM CO.,LTD. recognizes the crucial role of this intermediate in unlocking the potential of new drug therapies. Its primary utility lies in its function as a key component in the synthesis of important drugs, most notably Terazosin hydrochloride and Doxazosin. These medications are cornerstones in managing conditions such as hypertension and benign prostatic hyperplasia, impacting millions of lives globally. The precise molecular structure of 4-Amino-2-chloro-6,7-dimethoxyquinazoline makes it an ideal starting point for constructing these complex therapeutic molecules.

Beyond its direct application in established drug manufacturing, this compound is also a valuable asset in broader pharmaceutical R&D. Its unique chemical properties make it an attractive building block for exploring novel drug candidates or for creating reference standards used in analytical testing and quality control. The high purity (≥99.0%) offered by NINGBO INNO PHARMCHEM CO.,LTD. ensures its suitability for sensitive research applications, where even trace impurities can skew results. For those engaged in chemical synthesis and seeking a reliable pharmaceutical intermediate, the versatility of 4-Amino-2-chloro-6,7-dimethoxyquinazoline makes it a strategic choice.

By providing high-quality high purity chemical intermediates like 4-Amino-2-chloro-6,7-dimethoxyquinazoline, NINGBO INNO PHARMCHEM CO.,LTD. supports the innovation and progress within the pharmaceutical sector, enabling the development of next-generation treatments. Exploring its potential can significantly enhance your drug development initiatives.